פאנדי 100 יח'מל ( פקטור 8)

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

FACTOR VIII (HUMAN)

Disponibbli minn:

MEDICI MEDICAL LTD, ISRAEL

Kodiċi ATC:

B02BD02

Għamla farmaċewtika:

אבקה להכנת תמיסה לזריקה

Kompożizzjoni:

FACTOR VIII (HUMAN) 1000 IU

Rotta amministrattiva:

תוך-ורידי

Tip ta 'preskrizzjoni:

מרשם נדרש

Manifatturat minn:

INSTITUTO GRIFOLS S.A.,SPAIN,BARCELONA

Grupp terapewtiku:

COAGULATION FACTOR VIII

Żona terapewtika:

COAGULATION FACTOR VIII

Indikazzjonijiet terapewtiċi:

Is indicated for the prevention and control of bleeding in patients with moderate or severe factor VIII deficiency due to classical hemophilia A . Fanhdi is not effective in controlling the bleeding of patients with Von Willebrond's disease.

Data ta 'l-awtorizzazzjoni:

2020-12-31